Showing results (161-170 of 1,109) with videos related to

Sort By:
Pageof 111
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 23, 1998
Normal development of dental innervation and nerve/tissue interactions in the colony-stimulating factor-1 deficient osteopetrotic mouseS I Nagahama, M L Cunningham, M Y Lee, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 1, 2005
Command hallucinations among Asian patients with schizophreniaTheresa M Y Lee, Siow Ann Chong, Yiong Huat Chan, et al.
Nature Communications|November 4, 2021
Stability and molecular pathways to the formation of spin defects in silicon carbideElizabeth M Y Lee, Alvin Yu, Juan J de Pablo, et al.
Nature Reviews. Neuroscience|January 16, 2015
Spreading of pathology in neurodegenerative diseases: a focus on human studiesJohannes Brettschneider, Kelly Del Tredici, Virginia M-Y Lee, et al.
American Journal of Physical Medicine & Rehabilitation|January 1, 1997
Clinical trial of a cervical traction modality with electromyographic biofeedbackA M Wong, M Y Lee, W H Chang, et al.
Acta Neuropathologica Communications|June 2, 2018
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neuronsMichael X Henderson, Chao Peng, John Q Trojanowski, et al.
Cell Proliferation|October 1, 2008
A potential role of connexin 43 in epidermal growth factor-induced proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC, p44/42 and p38 MAPKs pathwaysJ H Park, M Y Lee, J S Heo, et al.
Diabetes Research and Clinical Practice|October 26, 2011
Higher-than-optimal body mass index and diabetes mortality in the Asia Pacific regionAlexandra L C Martiniuk, Crystal M Y Lee, Stephen Colagiuri, et al.
Archives of Neurology|December 15, 2004
Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusionsAnca Popescu, Carol F Lippa, Virginia M-Y Lee, et al.
Expert Opinion on Pharmacotherapy|June 7, 2005
Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairmentsJohn Q Trojanowski, Amos B Smith, Donna Huryn, et al.
Pageof 111